Anti Covid drug 2-DG launched by Defence Minister and Health Minister
Minister of Defence, Shri Rajnath Singh and Minister of Health and Family Welfare, Dr. Harsh Vardhan today jointly launched the new COVID drug 2-DG at DRDO Bhawan. The anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development […]
Government monitoring supply of each COVID-19 Essential Drug
Minister of State Shri Mansukh Mandaviya today assured that the Government is monitoring supply of each COVID-19 Essential Drug. All drugs used in the management of COVID-19 are now available in India by ramping up production and increasing the imports. The availability of these drugs is being monitored by implementing three-pronged strategy of Supply Chain […]
Government of India provides advance information on Vaccine Doses Supply availability till 15th June 2021 to States and UTs
The Liberalised Pricing & Accelerated National COVID-19 Vaccination Strategy has been implemented from 1st May 2021. As part of the Strategy, in every month 50% of the total Central Drugs Laboratory (CDL) cleared vaccine doses would be procured by Govt. of India, and GOI would continue to make it available to the State Govts totally […]
Dr. Harsh Vardhan reviews Public Health Response to COVID-19 and Progress of Vaccination with West Bengal and the 8 States of the North-East
Dr. Harsh Vardhan, Union Minister of Health and Family Welfare today interacted with State Health Ministers and Principal Secretaries/ Additional Chief Secretaries of West Bengal and the 8 States of the North-eastern Region in the presence of Shri Ashwini Kumar Choubey, Union Minister of State for Health and Family Welfare. These states are depicting a […]
Shri Sadananda Gowda reviews availability of Covid related medicines
Union Minister for Chemicals and Fertilizers Shri Sadananda Gowda held a meeting today with senior officials Department of Pharmaceuticals to review the availability of medicines being used in the management of COVID19. In a tweet shared by the Minister he said that Department of Pharmaceuticals is working closely with the States to ensure uninterrupted availability […]
Daily Recoveries more than 4 Lakh in the country, for the first time
In a landmark achievement, with the dedication and tireless effort of all the healthcare and frontline workers, India has recorded daily recoveries of more than 4 lakh COVID patients in a single day for the first time. 4,22,436 recoveries were registered in the last 24 hours. Average Daily Recovery of more than 3,55,944 cases has […]
Health Ministry flags Considerable Decline in COVID-19 Vaccination in some states/UTs.
The Union Health Ministry has flagged concerns regarding the considerably slow pace of COVID-19 vaccination across states and UTs and has urged them to significantly expedite the pace towards full vaccination coverage by saturating all eligible beneficiaries. This was communicated to all states and UTs by Shri Rajesh Bhushan, Union Health Secretary, as he reviewed […]
DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on 12.05.2021. […]
Union Government consistently and proactively working to secure and enhance the Availability of COVID Vaccines
There have been reports in a section of the media followed by some uninformed tweets alleging delay in licensing for Covaxin and delayed approval for technology transfer for manufacturing COVAXIN vaccine in the country. These news reports and the content mentioned in the tweet are completely baseless and factually incorrect. The Union Government is consistently […]
Gap between two doses of Covishield Vaccine extended from 6-8 weeks to 12-16 weeks based on recommendation of COVID Working Group
The COVID Working Group chaired by Dr N K Arora has recommended extension of the gap between the first and second doses of COVISHIELD vaccine to 12-16 weeks. The present gap between the two doses of COVISHIELD vaccine is 6-8 weeks. Based on the available real-life evidences, particularly from UK, the COVID-19 Working Group agreed […]
